Group 1 - The company, Jiangxi Jindalai Environmental Protection Co., Ltd., has approved an external investment plan to invest in Yunnan Jici Medical Technology Co., Ltd. [2][3] - The investment will be executed in three phases, with a total investment of RMB 150 million in the first phase, followed by RMB 50 million in the second phase, and the remaining funds after obtaining new drug clinical research approval [3][4] - The company aims to establish a concerted action relationship with Hu Min to jointly control Jici Medical in major decisions [3][4] Group 2 - The changes in the investment plan are expected to enhance the company's risk resistance and align with its long-term strategic development, without adversely affecting daily operations [5] - The investment is sourced from the company's own funds, which will not impose significant short-term cash flow pressure [8] - The company acknowledges the uncertainties and risks associated with drug development, including potential delays in clinical trials and regulatory approvals [9][10]
江西金达莱环保股份有限公司对外投资进展公告